Source: Annual Congress 2010 - COPD: comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Chaouch, I. Bachouch, M. Zarrouk, S. Cheikh Rouhou, B. Hamdi, S. Yaalaoui, H. Racil, A. Chabbou (Ariana, Tunisia). Proportion and impact of anemia in COPD patients. Eur Respir J 2010; 36: Suppl. 54, 514

Member's Comments

No comment yet.

Related content which might interest you: Clinical impact of anemia in patients with COPD Source: Annual Congress 2010 - COPD: comorbidities Year: 2010 Prevalence and determinants of anaemia in hospitalized elderly COPD patients Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD Year: 2008 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Occurrence and impact of bronchiectasis in patients with COPD Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Anemia in COPD patients with an exacerbation Source: Annual Congress 2011 - COPD exacerbation Year: 2011 Correction of the anemia of chronic disease among COPD patients Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity Year: 2020 Characterization of patients with severe COPD Source: International Congress 2018 – COPD around the world Year: 2018 Impact of moderate and severe exacerbations in severe COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 The impact of COVID-19 on patients with asthma Source: Eur Respir J, 57 (3) 2003142; 10.1183/13993003.03142-2020 Year: 2021 Role of comorbidities in stable COPD patients mortality Source: International Congress 2016 – Monitoring comorbidities Year: 2016 The impact of depression in recovery and outcome of patients hospitalized for COPD exacerbation Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011 The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Frequency and impact of bronchiectasis in a cohort of patients in a COPD clinic Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Influence of pneumonia on the survival of patients with COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Analysis of causes and quality of patients‘ treatment with often severe asthma exacerbations Source: Eur Respir J 2007; 30: Suppl. 51, 72s Year: 2007 The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients Year: 2013 Recognising the importance of anaemia in COPD Source: Annual Congress 2008 - COPD – the holistic perspective Year: 2008 Effect of roflumilast in patients with severe COPD and a history of hospitalisation Source: Eur Respir J, 50 (1) 1700158; 10.1183/13993003.00158-2017 Year: 2017